The Future of AI: Promise, Peril, Power
Artificial intelligence (AI) is transforming various domains, offering potential benefits but also ethical challenges. Implementing responsible development, open dialogue, and ...
- Latest
- Trending
Artificial intelligence (AI) is transforming various domains, offering potential benefits but also ethical challenges. Implementing responsible development, open dialogue, and ...
Japan's Nikkei surged to a 34-year high driven by tech rally & strong earnings. Investors are optimistic about the market's ...
Otsuka's phase 3 trial for AVP-786 in treating agitation in Alzheimer's patients has failed to meet the primary efficacy endpoint. ...
Connect Biopharma has appointed James Zuie-chin Huang to its Board of Directors. Huang brings over 30 years of biotech experience ...
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
Medical technology company TransMedics Group, Inc. is set to release its Q4 and full year 2023 financial results, highlighting its ...
YS Biopharma raises concerns about the validity of an extraordinary general meeting called by shareholders. The company also faces financial ...
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...
AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.